Chronic myeloid leukemia
CL Sawyers - New England Journal of Medicine, 1999 - Mass Medical Soc
New England Journal of Medicine, 1999•Mass Medical Soc
In the past decade clinical and laboratory studies have led to important new insights into the
biology of chronic myeloid leukemia (CML). Basic science has defined the molecular
pathogenesis of CML as unregulated signal transduction by a tyrosine kinase. Clinical
science has demonstrated that it is curable through immune-mediated elimination of
leukemia cells by allogeneic T lymphocytes. Clinical Features CML is a malignant clonal
disorder of hematopoietic stem cells that results in increases in not only myeloid cells but …
biology of chronic myeloid leukemia (CML). Basic science has defined the molecular
pathogenesis of CML as unregulated signal transduction by a tyrosine kinase. Clinical
science has demonstrated that it is curable through immune-mediated elimination of
leukemia cells by allogeneic T lymphocytes. Clinical Features CML is a malignant clonal
disorder of hematopoietic stem cells that results in increases in not only myeloid cells but …
In the past decade clinical and laboratory studies have led to important new insights into the biology of chronic myeloid leukemia (CML). Basic science has defined the molecular pathogenesis of CML as unregulated signal transduction by a tyrosine kinase. Clinical science has demonstrated that it is curable through immune-mediated elimination of leukemia cells by allogeneic T lymphocytes.
Clinical Features
CML is a malignant clonal disorder of hematopoietic stem cells that results in increases in not only myeloid cells but also erythroid cells and platelets in peripheral blood and marked myeloid hyperplasia in the bone marrow (Figure 1A, Figure 1B, andFigure 1C). . . .
The New England Journal Of Medicine